{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:39:29Z","timestamp":1791218369349,"version":"4.1.0"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T00:00:00Z","timestamp":1668988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a single-stranded RNA virus that causes coronavirus disease 2019 (COVID-19). One of the main topics of conversation in these past months in the world of immunology has been the issue of how patients with immune defects will fare if they contract this infection. To date there has been limited data on larger cohorts of patients with Inborn Errors of Immunity (IEI) diagnosed with COVID-19. Here, we review the data of COVID-19 infections in a single center cohort of 113 patients from the Mount Sinai Immunodeficiency program, who had 132 infections between January 2020 and June 2022. This included 56 males and 57 females, age range 2 - 84 (median 42). The mortality rate was 3%. Comparison between admitted patients revealed a significantly increased risk of hospitalization amongst the unvaccinated patients, 4% vaccinated vs 40% unvaccinated; odds ratio 15.0 (95% CI 4.2 \u2013 53.4; p &amp;lt;0.00001). Additionally, COVID anti-spike antibody levels, determined in 36 of these patients post vaccination and before infection, were highly variable.<\/jats:p>","DOI":"10.3389\/fimmu.2022.1035571","type":"journal-article","created":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T12:34:37Z","timestamp":1669034077000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["SARS-COV-2 infections in inborn errors of immunity: A single center study"],"prefix":"10.3389","volume":"13","author":[{"given":"Kimberley","family":"Cousins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"DeFelice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley Sang Eun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Rotella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faris","family":"Jaber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shradha","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsi-en","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Cunningham-Rundles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2006874117","article-title":"The airborne lifetime of small speech droplets and their potential importance in SARS-CoV-2 transmission","volume":"117","author":"Stadnytskyi","year":"2020","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/cea.13746","article-title":"Expression of ACE2 in airways: Implication for COVID-19 risk and disease management in patients with chronic inflammatory respiratory diseases","volume":"50","author":"Yao","year":"2020","journal-title":"Clin Exp Allergy"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-021-01065-9","article-title":"COVID-19 in patients with primary immunodeficiency","volume":"41","author":"Esenboga","year":"2021","journal-title":"J Clin Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.jaip.2020.09.052","article-title":"Clinical outcomes and features of COVID-19 in patients with primary immunodeficiencies in new York city","volume":"9","author":"Ho","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B6","volume-title":"WHO coronavirus (COVID-19) dashboard","year":"2021"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s42399-020-00363-4","article-title":"Comorbidity and its impact on patients with COVID-19","volume":"2","author":"Sanyaolu","year":"2020","journal-title":"SN Compr Clin Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s10875-020-00758-x","article-title":"Human inborn errors of immunity: 2019 update of the IUIS phenotypical classification","volume":"40","author":"Bousfiha","year":"2020","journal-title":"J Clin Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"21526575221096044","DOI":"10.1177\/21526575221096044","article-title":"COVID-19 infection in patients with humoral immunodeficiency: A case series and literature review","volume":"13","author":"Jalil","year":"2022","journal-title":"Allergy Rhinol (Providence)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2022.03.017","article-title":"Response to SARS-CoV-2 initial series and additional dose vaccine in patients with predominant antibody deficiency","volume":"10","author":"Barmettler","year":"2022","journal-title":"J Allergy Clin Immunol: In Pract"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-020-00928-x","article-title":"Impact of SARS-CoV-2 pandemic on patients with primary immunodeficiency","volume":"41","author":"Delavari","year":"2021","journal-title":"J Clin Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.09.010","article-title":"Coronavirus disease 2019 in patients with inborn errors of immunity: An international study","volume":"147","author":"Meyts","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2021.05.029","article-title":"Immunogenicity of pfizer-BioNTech COVID-19 vaccine in patients with inborn errors of immunity","volume":"148","author":"Hagin","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J BioMed Inform"},{"key":"B15","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: Building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J BioMed Inform"},{"key":"B16","volume-title":"Coronavirus disease 2019 (COVID-19) in New York City","year":"2022"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2110345","article-title":"Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine through 6 months","volume":"385","author":"Thomas","year":"2021","journal-title":"N Engl J Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2107809","article-title":"Safety and efficacy of single-dose Ad26.COV2.S vaccine against covid-19","volume":"384","author":"Sadoff","year":"2021","journal-title":"N Engl J Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"108803","DOI":"10.1016\/j.clim.2021.108803","article-title":"COVID-19 prevalence and outcomes in patients receiving biologic therapies at an infusion center in New York City","volume":"230","author":"Harada","year":"2021","journal-title":"Clin Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1016\/j.anai.2021.08.029","article-title":"Detection of SARS-COV-2 antibodies in immunglobulin products","volume":"127","author":"Cousins","year":"","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1016\/j.jaip.2022.06.020","article-title":"Passive immunization against COVID-19 by anti-SARS-CoV-2 spike IgG in commercially available immunoglobulin preparations in severe antibody deficiency","volume":"10","author":"Hirsiger","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01678-y","article-title":"An infectious SARS-CoV-2 B.1.1.529 omicron virus escapes neutralization by therapeutic monoclonal antibodies","volume":"28","author":"VanBlargan","year":"2022","journal-title":"Nat Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-021-01077-5","article-title":"COVID-19 in the context of inborn errors of immunity: a case series of 31 patients from Mexico","volume":"41","author":"Castano-Jaramillo","year":"2021","journal-title":"J Clin Immunol"},{"key":"B25","volume-title":"Mortality analyses","year":"2022"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-022-01264-y","article-title":"The impact of SARS-CoV-2 infection in patients with inborn errors of immunity: the experience of the Italian primary immunodeficiencies network (IPINet)","volume":"42","author":"Giardino","year":"2022","journal-title":"J Clin Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03841-4","article-title":"Rapid and stable mobilization of CD8(+) T cells by SARS-CoV-2 mRNA vaccine","volume":"597","author":"Oberhardt","year":"2021","journal-title":"Nature"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-01122-w","article-title":"The T cell immune response against SARS-CoV-2","volume":"23","author":"Moss","year":"2022","journal-title":"Nat Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01049-10","article-title":"T Cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice","volume":"84","author":"Zhao","year":"2010","journal-title":"J Virol"},{"key":"B30","unstructured":"Coronavirus (COVID-19) mortality rate 2022"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2022.2034936","article-title":"Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and paxlovid) for COVID-19a meta-analysis","volume":"54","author":"Wen","year":"2022","journal-title":"Ann Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-021-01193-2","article-title":"Case series: Convalescent plasma therapy for patients with COVID-19 and primary antibody deficiency","volume":"42","author":"Lang-Meli","year":"2022","journal-title":"J Clin Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1035571\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T12:34:41Z","timestamp":1669034081000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1035571\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,21]]},"references-count":32,"alternative-id":["10.3389\/fimmu.2022.1035571"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.1035571","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,21]]},"article-number":"1035571"}}